Alumis Shares Are Trading Lower. The Company Presented the 28-week Open Label Extension Period Data From Its Phase 2 STRIDE Trial of ESK-001.
Alumis Shares Are Trading Lower. The Company Presented the 28-week Open Label Extension Period Data From Its Phase 2 STRIDE Trial of ESK-001.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.